StockWatch
·

INDRAPRASTHA MEDICAL CORP.LTD. Q3 FY25 Results

INDRAMEDCOQ3 FY25 Results
Filing
MetricValue ( Cr)vs Q2 FY25
Revenue324.937.1%
Total Income330.067.3%
Expenditure285.534.5%
PBT44.5321.8%
Net Profit32.8122.6%
OPM8.19%2.71pp
NPM9.94%1.97pp
EPS3.5822.7%
View full financials

Informational and educational content only. Not investment advice.